Pfizer says pill cuts severe COVID risk by 89%
A trial of Pfizer's experimental antiviral pill for COVID-19 was stopped early after the drug was shown to cut by 89% the chances of hospitalization or death for adults at risk of developing severe disease, the company said.
Comentarios
Publicar un comentario
Leave a comment. Thanks!
Comentarios de Facebook